Patents/Inventors

Pablo Umaña

SchlierenCH22 patents

14 Patents

US126007812026
Tumor-targeted Agonistic CD28 Antigen Binding Molecules
Hoffmann-la Roche Inc.
0 cites
US125655302026
Combination Therapy with Targeted 4-1BB (CD137) Agonists/anti-fap Binding Domain and Anti-cea/anti-cd3 Bispecific Antibody
Hoffmann-la Roche Inc.
0 cites
US124733732025
Bispecific Antibody Molecules Binding to CD3 and Egfrviii
Hoffmann-la Roche Inc.
0 cites
US122151552025
Antibodies Binding to CD3 and CD19
Hoffmann-la Roche Inc.
0 cites
US121459942024
Bispecific Antigen Binding Molecules Capable of Specific Binding to CD40 and to Fap
Hoffmann-la Roche Inc.
0 cites
US120982132024
Antibodies Binding to HLA-A2/WT1
Hoffmann-la Roche Inc.
0 cites
US120495152024
Agonistic CD28 Antigen Binding Molecules Targeting Her2
Hoffmann-la Roche Inc.
0 cites
US119876322024
Antibodies Binding to HLA-A2/MAGE-A4
Hoffmann-la Roche Inc.
0 cites
US117809202023
Antibodies Binding to CD3 and CD19
Hoffmann-la Roche Inc.
0 cites
US117186802023
Combination Therapy of Anti-cd20/anti-cd3 Bispecific Antibodies and 4-1BB (CD137) Agonists
Hoffmann-la Roche Inc.
0 cites
US116728582023
Bispecific Antibody Molecules Binding to CD3 and TYRP-1
Hoffmann-la Roche Inc.
0 cites
US116393942023
Bispecific Antigen Binding Molecule for a Costimulatory TNF Receptor
Hoffmann-la Roche Inc.
0 cites
US116083762023
Tumor-targeted Agonistic CD28 Antigen Binding Molecules
Hoffmann-la Roche Inc.
0 cites
US115913972023
Bispecific Antibody Molecules Binding to CD3 and Egfrviii
Hoffmann-la Roche Inc.
0 cites